CWM
VYGR icon

CIBC World Markets’s Voyager Therapeutics VYGR Stock Holding History

CIBC World Markets’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,207
Closed -$34.5K – 1953
2025
Q1 		$34.5K Buy
+10,207
New +$47.7K ﹤0.01% 1758

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Markets's VYGR Position: Q2 2025 in Review

CIBC World Markets sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 10,207 shares — an estimated $34.5K sold.

CIBC World Markets first reported a position in VYGR in Q1 2025 and held it in 1 quarter. The position peaked at $34.5K in Q1 2025. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.

  • CIBC World Markets reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 10,207 Voyager Therapeutics shares in Q2 2025, an estimated $34.5K.
  • CIBC World Markets first reported a position in Voyager Therapeutics in Q1 2025 and held it in 1 quarter.
  • CIBC World Markets's Voyager Therapeutics position peaked at $34.5K in Q1 2025.
  • 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.